What is the ticker symbol for Scinai Immunotherapeutics?

Scinai Immunotherapeutics trades under the ticker SCNI on NASDAQ.

What sector does Scinai Immunotherapeutics operate in?

Scinai Immunotherapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SCNI in a portfolio?

PortView shows SCNI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Scinai Immunotherapeutics (SCNI) Stock Analysis

NASDAQHealthcareBiotechnology

$2.40-2.44%

1-year price historyRange $2.28 – $16.30

52-week range$2.40

$2.15$16.80

What Scinai Immunotherapeutics does

Scinai Immunotherapeutics Ltd. operates as an emerging biopharmaceutical company, dedicated to the research, production, and market introduction of medical solutions. Based in Israel, its primary objective is the prevention and treatment of a range of infectious, autoimmune, and other health conditions. The company maintains a significant licensing and collaboration agreement with the Max Planck Society and the University Medical Center Göttingen. This partnership is focused on advancing and commercializing a nanosized antibody (NanoAb) specifically for COVID-19, in addition to pursuing NanoAb applications for various other disease indications. Established in 2003, the company was formerly known as BiondVax Pharmaceuticals Ltd. before rebranding to Scinai Immunotherapeutics Ltd. in September 2023. Its corporate headquarters are situated in Jerusalem, Israel.

Key metrics

Market cap

$1.24M

P/E (TTM)

-0.17

EPS (TTM)

$-14.23

Beta

2.08

Dividend yield

0.00%

Revenue / share

$0.03

50-day avg

$2.60

200-day avg

$6.11

52-week high

$16.80

52-week low

$2.15

CEO

Amir Reichman

ETFs linked to SCNI

Broad-market and Healthcare sector ETFs an investor holding Scinai Immunotherapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SCNI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SCNI in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Scinai Immunotherapeutics?: Scinai Immunotherapeutics trades under the ticker SCNI on NASDAQ.
Which exchange is SCNI listed on?: SCNI is listed on NASDAQ.
What sector does Scinai Immunotherapeutics operate in?: Scinai Immunotherapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SCNI in a portfolio?: PortView shows SCNI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.